The awarding ceremony of the “Selection of Most Valuable Companies Listed in China for 2012”, which was co-sponsored by the "Securities Times" and the "New Fortune" magazines with China Association for Public Companies as the authoritative guidance institution, was held recently in Shenzhen. Boasting of its stable operation, outstanding performance and good corporate governance, Huadong Medicine stood out from over 1,400 companies listed on the main board of Shanghai Stock Exchange and Shenzhen Stock Exchange, ranking No. 37 on the list of the “100 Most Valuable Main-Board-Listed Companies in China for 2012”. Chen Bo (the board secretary of Huadong Medicine) was granted the award of being one of the "100 Best Board Secretaries of Main-Board-Listed Companies in China for 2012 ".
LATEST NEWS
Grand Pharma brings heavyweight products to the World Health Expo
2023-04-12
Grand Pharma Recognized as a National Technology Innovation Demonstration Enterprise
2022-11-09
Globally innovative products Atectura® and Enerzair® developed by Grand Pharma officially enter the domestic market
2022-09-06
Accelerating Global Innovation, Opening Ceremony of Grand Pharma Optics Valley R&D Center and Extensive Intervention Production and R&D Platform
2022-08-24
SIR-Spheres® Yttrium-90 Microspheres Injections Introduced by Grandpharma Officially Launched in Chinese Market
2022-06-22
Yuanda Shuyang's New Production Base for Blood Products Officially Put into Operation
2022-04-15